These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24220306)
1. Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA. Takeshita A; Iwai S; Morita Y; Niki-Yonekawa A; Hamada M; Yura Y Int J Oncol; 2014 Jan; 44(1):59-68. PubMed ID: 24220306 [TBL] [Abstract][Full Text] [Related]
2. Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway. Li YY; Zhou CX; Gao Y Biochem Biophys Res Commun; 2014 Sep; 452(3):490-6. PubMed ID: 25172658 [TBL] [Abstract][Full Text] [Related]
3. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells. Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938 [TBL] [Abstract][Full Text] [Related]
4. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma. Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373 [TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells. Katase N; Lefeuvre M; Tsujigiwa H; Fujii M; Ito S; Tamamura R; Buery RR; Gunduz M; Nagatsuka H Oncol Rep; 2013 Apr; 29(4):1349-55. PubMed ID: 23354949 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673 [TBL] [Abstract][Full Text] [Related]
8. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Chang KW; Kao SY; Wu YH; Tsai MM; Tu HF; Liu CJ; Lui MT; Lin SC Oral Oncol; 2013 Jan; 49(1):27-33. PubMed ID: 22854067 [TBL] [Abstract][Full Text] [Related]
9. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells. Zuo Y; Wu Y; Chakraborty C J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528 [TBL] [Abstract][Full Text] [Related]
10. Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer. Yan G; Zou R; Chen Z; Fan B; Wang Z; Wang Y; Yin X; Zhang D; Tong L; Yang F; Jiang W; Fu W; Zheng J; Bergo MO; Dalin M; Zheng J; Chen S; Zhou J Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):682-90. PubMed ID: 25001480 [TBL] [Abstract][Full Text] [Related]
11. Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma. Lai SY; Ziober AF; Lee MN; Cohen NA; Falls EM; Ziober BL Oral Oncol; 2008 Jul; 44(7):683-8. PubMed ID: 17996485 [TBL] [Abstract][Full Text] [Related]
12. Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma. Lin CW; Sun MS; Wu HC Int J Oncol; 2014 Aug; 45(2):710-8. PubMed ID: 24821609 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells. Yamamura M; Noguchi K; Nakano Y; Segawa E; Zushi Y; Takaoka K; Kishimoto H; Hashimoto-Tamaoki T; Urade M Int J Oncol; 2013 Mar; 42(3):873-80. PubMed ID: 23292068 [TBL] [Abstract][Full Text] [Related]
14. Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells. Hamada M; Miki T; Iwai S; Shimizu H; Yura Y Cancer Chemother Pharmacol; 2011 Sep; 68(3):559-69. PubMed ID: 21107573 [TBL] [Abstract][Full Text] [Related]
15. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis. Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610 [TBL] [Abstract][Full Text] [Related]
17. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959 [TBL] [Abstract][Full Text] [Related]
18. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling. Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1. Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]